{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:38:41Z","timestamp":1787240321305,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PSU Reinventing University Grant","award":["175623"],"award-info":[{"award-number":["175623"]}]},{"name":"Wuxi Municipal Health commission Youth Project","award":["Q202230"],"award-info":[{"award-number":["Q202230"]}]},{"name":"Top Talent Support Program for Youth and Middle-aged People of Wuxi Health Committee","award":["BJ2023063"],"award-info":[{"award-number":["BJ2023063"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03076-7","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:44:30Z","timestamp":1760431470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimetastatic effects of chamuangone-enriched extract in breast cancer lung metastasis: in vitro and in vivo evidence"],"prefix":"10.1007","volume":"42","author":[{"given":"Asad Ur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pharkphoom","family":"Panichayupakaranant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"17","key":"3076_CR1","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1056\/NEJMoa2404625","volume":"391","author":"NC Turner","year":"2024","unstructured":"Turner NC, et al. Inavolisib-based therapy in PIK3CA-mutated advanced breast cancer. N Engl J Med. 2024;391(17):1584\u201396.","journal-title":"N Engl J Med"},{"issue":"6","key":"3076_CR2","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(6):477\u201395.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3076_CR3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","volume":"19","author":"L Jin","year":"2018","unstructured":"Jin L, et al. Breast cancer lung metastasis: molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19(10):858\u201368.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"3076_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023;10(4):1367\u2013401.","journal-title":"Genes Dis"},{"key":"3076_CR5","doi-asserted-by":"publisher","first-page":"104525","DOI":"10.1016\/j.fbio.2024.104525","volume":"61","author":"AU Rahman","year":"2024","unstructured":"Rahman AU, Panichayupakaranant P. Exploring the diverse biological activities of Garcinia cowa: implications for future cancer chemotherapy and beyond. Food Biosci. 2024;61:104525.","journal-title":"Food Biosci"},{"key":"3076_CR6","doi-asserted-by":"publisher","first-page":"106730","DOI":"10.1016\/j.jff.2025.106730","volume":"127","author":"AU Rahman","year":"2025","unstructured":"Rahman AU, et al. A standardized chamuangone enriched extract shows anticancer efficacy in allograft models of metastatic breast cancer. J Funct Foods. 2025;127:106730.","journal-title":"J Funct Foods"},{"issue":"3","key":"3076_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/jphp.13216","volume":"72","author":"P Sae-Lim","year":"2020","unstructured":"Sae-Lim P, et al. Chamuangone from Garcinia cowa leaves inhibits cell proliferation and migration and induces cell apoptosis in human cervical cancer in vitro. J Pharm Pharmacol. 2020;72(3):470\u201380.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"3076_CR8","first-page":"38","volume":"6","author":"A Sakunpak","year":"2017","unstructured":"Sakunpak A, et al. Isolation of chamuangone, a cytotoxic compound against Leishmania major and cancer cells from Garcinia cowa leaves and its HPLC quantitative determination method. J Cancer Res Updat. 2017;6(2):38\u201345.","journal-title":"J Cancer Res Updat"},{"key":"3076_CR9","doi-asserted-by":"publisher","DOI":"10.4103\/pm.pm_472_18","author":"P Sae-Lim","year":"2019","unstructured":"Sae-Lim P, Yuenyongsawad S, Panichayupakaranant P. Chamuangone-enriched Garcinia cowa leaf extract with rice bran oil: extraction and cytotoxic activity against cancer cells. Pharmacogn Mag. 2019. https:\/\/doi.org\/10.4103\/pm.pm_472_18.","journal-title":"Pharmacogn Mag"},{"key":"3076_CR10","doi-asserted-by":"publisher","first-page":"118625","DOI":"10.1016\/j.jep.2024.118625","volume":"335","author":"AU Rahman","year":"2024","unstructured":"Rahman AU, et al. A standardized chamuangone enriched extract from Garcinia cowa Roxb. leaves shows acute and sub-acute safety. J Ethnopharmacol. 2024;335:118625.","journal-title":"J Ethnopharmacol"},{"issue":"221","key":"3076_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin VI, et al. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6(221):221ra15-221ra15.","journal-title":"Sci Transl Med"},{"issue":"9","key":"3076_CR12","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/ijms20092272","volume":"20","author":"B Medeiros","year":"2019","unstructured":"Medeiros B, Allan AL. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. Int J Mol Sci. 2019;20(9):2272.","journal-title":"Int J Mol Sci"},{"key":"3076_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.fct.2019.02.020","volume":"126","author":"X Jiang","year":"2019","unstructured":"Jiang X, et al. Scandenolone from Cudrania tricuspidata fruit extract suppresses the viability of breast cancer cells (MCF-7) in vitro and in vivo. Food Chem Toxicol. 2019;126:56\u201366.","journal-title":"Food Chem Toxicol"},{"key":"3076_CR14","doi-asserted-by":"publisher","first-page":"106610","DOI":"10.1016\/j.bioorg.2023.106610","volume":"138","author":"WA Badawi","year":"2023","unstructured":"Badawi WA, et al. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Bioorg Chem. 2023;138:106610.","journal-title":"Bioorg Chem"},{"key":"3076_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.fct.2016.11.034","volume":"99","author":"A Zafar","year":"2017","unstructured":"Zafar A, Singh S, Naseem I. Cytotoxic activity of soy phytoestrogen coumestrol against human breast cancer MCF-7 cells: insights into the molecular mechanism. Food Chem Toxicol. 2017;99:149\u201361.","journal-title":"Food Chem Toxicol"},{"key":"3076_CR16","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.","journal-title":"Int Immunopharmacol"},{"key":"3076_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2024.e02308","author":"EEJ Iweala","year":"2024","unstructured":"Iweala EEJ, Amuji DN, Nnaji FC. Protein biomarkers for diagnosis of breast cancer. Sci Afr. 2024. https:\/\/doi.org\/10.1016\/j.sciaf.2024.e02308.","journal-title":"Sci Afr"},{"issue":"2","key":"3076_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-012-2164-8","volume":"135","author":"P Kabos","year":"2012","unstructured":"Kabos P, et al. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. Breast Cancer Res Treat. 2012;135(2):415\u201332.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"3076_CR19","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.tranon.2021.101045","volume":"14","author":"Q Wang","year":"2021","unstructured":"Wang Q, et al. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348\/ATG7 axis. Transl Oncol. 2021;14(8):101045.","journal-title":"Transl Oncol"},{"key":"3076_CR20","doi-asserted-by":"publisher","first-page":"103035","DOI":"10.1016\/j.redox.2024.103035","volume":"70","author":"M Shen","year":"2024","unstructured":"Shen M, et al. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT. Redox Biol. 2024;70:103035.","journal-title":"Redox Biol"},{"key":"3076_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jff.2017.05.049","volume":"35","author":"M Wang","year":"2017","unstructured":"Wang M, et al. Bioassay-guided isolation of glycoprotein SPG-56 from sweet potato Zhongshu-1 and its anti-colon cancer activity in vitro and in vivo. J Funct Foods. 2017;35:315\u201324.","journal-title":"J Funct Foods"},{"issue":"1","key":"3076_CR22","doi-asserted-by":"publisher","first-page":"15117","DOI":"10.1038\/s41598-024-65821-8","volume":"14","author":"S Malik","year":"2024","unstructured":"Malik S, et al. Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients. Sci Rep. 2024;14(1):15117.","journal-title":"Sci Rep"},{"issue":"1","key":"3076_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0115748928251754230922095544","volume":"20","author":"RA Reddy","year":"2025","unstructured":"Reddy RA, Varshini MS, Kumar RS. Matrix metalloproteinase-2 (MMP-2): as an essential factor in cancer progression. Recent Pat Anti-Cancer Drug Discov. 2025;20(1):26\u201344.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"key":"3076_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2024.2398636","author":"TN Shenoy","year":"2024","unstructured":"Shenoy TN, Abdul Salam AA. Therapeutic potential of dietary bioactive compounds against anti-apoptotic Bcl-2 proteins in breast cancer. Crit Rev Food Sci Nutr. 2024. https:\/\/doi.org\/10.1080\/10408398.2024.2398636.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"3076_CR25","first-page":"7054134","volume":"2021","author":"C Ameh-Mensah","year":"2021","unstructured":"Ameh-Mensah C, et al. The analysis of bcl-2 in association with p53 and ki-67 in triple negative breast cancer and other molecular subtypes in ghana. J Oncology. 2021;2021(1):7054134.","journal-title":"J Oncology"},{"key":"3076_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2022.05.001","volume":"67","author":"N Ebrahimi","year":"2022","unstructured":"Ebrahimi N, et al. Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment. Cytokine Growth Factor Rev. 2022;67:11\u201324.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3076_CR27","doi-asserted-by":"crossref","unstructured":"Fu, X., et al., 2019. Molecular mechanisms of endocrine resistance. Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER, 265\u2013307.","DOI":"10.1007\/978-3-319-99350-8_11"},{"key":"3076_CR28","doi-asserted-by":"publisher","first-page":"607209","DOI":"10.3389\/fcell.2020.607209","volume":"8","author":"S Yang","year":"2021","unstructured":"Yang S, Liu Q, Liao Q. Tumor-associated macrophages in pancreatic ductal adenocarcinoma: origin, polarization, function, and reprogramming. Front Cell Dev Biol. 2021;8:607209.","journal-title":"Front Cell Dev Biol"},{"issue":"22","key":"3076_CR29","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, et al. Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011;103(22):1656\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3076_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, et al. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174\u201383.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3076_CR31","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, et al. Ki67 is a promising molecular target in the diagnosis of cancer. Mol Med Rep. 2015;11(3):1566\u201372.","journal-title":"Mol Med Rep"},{"issue":"16","key":"3076_CR32","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.3390\/cancers13164057","volume":"13","author":"Y-Y Wang","year":"2021","unstructured":"Wang Y-Y, et al. Cd44 promotes lung cancer cell metastasis through erk\u2013zeb1 signaling. Cancers (Basel). 2021;13(16):4057.","journal-title":"Cancers (Basel)"},{"key":"3076_CR33","doi-asserted-by":"publisher","first-page":"866014","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore SG, et al. IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front Oncol. 2022;12:866014.","journal-title":"Front Oncol"},{"issue":"4","key":"3076_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","volume":"102","author":"Y-D Wu","year":"2010","unstructured":"Wu Y-D, Zhou B. TNF-\u03b1\/NF-\u03baB\/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102(4):639\u201344.","journal-title":"Br J Cancer"},{"key":"3076_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","volume":"25","author":"F Balkwill","year":"2006","unstructured":"Balkwill F. TNF-\u03b1 in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409\u201316.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"3076_CR36","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/ijms24044002","volume":"24","author":"O Habanjar","year":"2023","unstructured":"Habanjar O, et al. Crosstalk of inflammatory cytokines within the breast tumor microenvironment. Int J Mol Sci. 2023;24(4):4002.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3076_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/156800911795655985","volume":"11","author":"S Sharma","year":"2011","unstructured":"Sharma S, Sharma R, Tyagi T. VEGF\/VEGFR pathway inhibitors as anti-angiogenic agents: present and future. Curr Cancer Drug Targets. 2011;11(5):624\u201353.","journal-title":"Curr Cancer Drug Targets"},{"key":"3076_CR38","doi-asserted-by":"publisher","first-page":"154923","DOI":"10.1016\/j.prp.2023.154923","volume":"252","author":"J Milovanovi\u0107","year":"2023","unstructured":"Milovanovi\u0107 J, et al. Vascular endothelial growth factor (VEGF)-A,-C and VE-cadherin as potential biomarkers in early breast cancer patients. Pathol Res Pract. 2023;252:154923.","journal-title":"Pathol Res Pract"},{"key":"3076_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3367","volume":"14","author":"M Rezaei","year":"2012","unstructured":"Rezaei M, et al. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression. Breast Cancer Res. 2012;14:1\u201315.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"3076_CR40","doi-asserted-by":"publisher","first-page":"2005420","DOI":"10.1080\/21688370.2021.2005420","volume":"10","author":"SN Rubtsova","year":"2022","unstructured":"Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers. 2022;10(4):2005420.","journal-title":"Tissue Barriers"},{"issue":"4","key":"3076_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0960-7404(01)00010-X","volume":"9","author":"WG Jiang","year":"2000","unstructured":"Jiang WG, Mansel RE. E-cadherin complex and its abnormalities in human breast cancer. Surg Oncol. 2000;9(4):151\u201371.","journal-title":"Surg Oncol"},{"issue":"10","key":"3076_CR42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3109\/07357900902769749","volume":"27","author":"N Makrilia","year":"2009","unstructured":"Makrilia N, et al. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009;27(10):1023\u201337.","journal-title":"Cancer Invest"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03076-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:33:16Z","timestamp":1762425196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03076-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures complied with the ARRIVE guidelines and were conducted under protocols approved by the Animal Care and Use Committee of Zhejiang University of Science and Technology (Approval No: MGS20231227201).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"517"}}